---
title: "Newamsterdam Pharma (NAMS.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/NAMS.US/norm.md"
symbol: "NAMS.US"
name: "Newamsterdam Pharma"
parent: "https://longbridge.com/zh-CN/quote/NAMS.US.md"
datetime: "2026-03-14T20:19:59.350Z"
locales:
  - [en](https://longbridge.com/en/quote/NAMS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NAMS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NAMS.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/NAMS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NAMS.US/norm.md)


# Newamsterdam Pharma (NAMS.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.6244 | -0.6051 | -0.1465 | -0.3404 | -0.9270 |
| ROE | -42.46% | -38.24% | -8.93% | -20.60% | -64.89% |
| Revenue | 32000.00 | 348000.00 | 19.14M | 2.98M | 12.77M |
| Net income | -74.92M | -72.00M | -17.36M | -39.53M | -92.18M |
| Operating income | -65.98M | -55.14M | -35.63M | -68.92M | -43.23M |
| Gross margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Net margin | -234134.38% | -20691.09% | -90.70% | -1327.30% | -721.71% |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 769.28M | 786.43M | 815.11M | 818.41M | 864.62M |
| Leverage | 1.13 | 1.08 | 1.05 | 1.05 | 1.14 |
| BVPS | 5.97 | 6.43 | 6.92 | 6.93 | 7.01 |
| Turnover | 0.0275 | 0.0575 | 0.1015 | 0.0721 | 0.0752 |
| Cash & STI | 636.24M | 702.95M | 739.16M | 808.48M | 834.19M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 568000.00 | 569000.00 | 620000.00 | 607000.00 | 673000.00 |
| Net debt | -728.65M | -755.77M | -783.01M | -808.09M | -833.74M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -40.88M | -32.77M | -37.67M | -36.47M | -37.48M |
| Investing CF | -21.14M | 2.51M | -159.14M | 2.85M | -62.18M |
| Financing CF | 13.68M | 5.89M | 3.42M | 6.52M | 456.61M |
| Free CF | -9.77M | 3.68M | -33.37M | -73.44M | 34.02M |
| OCF coverage | -40875.00% | -78021.43% | -42807.95% | -227925.00% | -1249366.67% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -100000.00 | -42000.00 | -88000.00 | -16000.00 | -3000.00 |